Safety and efficacy of durvalumab (MEDI4736) a PD-L1 antibody, in urothelial bladder cancer Meeting Abstract
| Authors: | Massard, C.; Gordon, M. S.; Sharma, S.; Rafii, S.; Wainberg, Z. A.; Luke, J. J.; Curiel, T. J.; Colon-Otero, G.; Hamid, O.; Sanborn, R. E.; O'Donnell, P. H.; Drakaki, A.; Kurland, J.; Rebelatto, M. C.; Jin, X. P.; Blake-Haskins, J. A.; Gupta, A. K.; Segal, N. H. |
| Abstract Title: | Safety and efficacy of durvalumab (MEDI4736) a PD-L1 antibody, in urothelial bladder cancer |
| Meeting Title: | 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2016 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-05-20 |
| Start Page: | 244s |
| Language: | English |
| ACCESSION: | WOS:000404665407075 |
| DOI: | 10.1200/JCO.2016.34.15_suppl.4502 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 4502 -- Source: Wos |
